Trouble for JnJ: Carcinogen found in some Aveeno, Neutrogena sunscreens, products recalled

JnJ said consumers should stop using the affected products and appropriately discard them.

Published On 2021-07-16 06:38 GMT   |   Update On 2021-07-16 06:38 GMT

New Delhi: Johnson and Johnson said on Wednesday it is voluntarily recalling all lots of five Neutrogena and Aveeno brand aerosol sunscreen products from the market after detecting a cancer-causing chemical in some samples.After internal testing identified low levels of benzene in some samples, JnJ said it has decided to recall these products from the market.Benzene is classified as a...

Login or Register to read the full article

New Delhi: Johnson and Johnson said on Wednesday it is voluntarily recalling all lots of five Neutrogena and Aveeno brand aerosol sunscreen products from the market after detecting a cancer-causing chemical in some samples.

After internal testing identified low levels of benzene in some samples, JnJ said it has decided to recall these products from the market.
Benzene is classified as a human carcinogen, a substance that could potentially cause cancer depending on the level and extent of exposure.
"While benzene is not an ingredient in any of our sunscreen products, it was detected in some samples of the impacted aerosol sunscreen finished products," the company said.
"Daily exposure to benzene in these aerosol sunscreen products at the levels detected in our testing would not be expected to cause adverse health consequences."
However, the company said it is recalling all lots of these specific aerosol sunscreen products out of caution.
The recalled aerosol sunscreens are Neutrogena Beach Defense, Neutrogena Cool Dry Sport, Neutrogena Invisible Daily defense, Neutrogena Ultra Sheer, and Aveeno Protect + Refresh.
JnJ said consumers should stop using the affected products and appropriately discard them.
Consumers should contact their physician or healthcare provider if they have any concerns, questions or have experienced any problems related to using these products.
Tags:    
Article Source : Reuters

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News